Is Hims & Hers the next big player in telehealth? Our experts break down its business model, growth potential, and the risks ...

The Details: NuScale Power reported quarterly losses of 13 cents per share, which missed the Street estimate for losses of 12 ...

The Details: Trade Desk reported quarterly earnings of 41 cents per share, in line with the analyst estimate, according to ...

Novo Nordisk A/S (NYSE: NVO) is one of the top oversold NYSE stocks to buy now. In a report released on August 4, Emily Field from Barclays maintained a Hold rating on Novo Nordisk A/S (NYSE:NVO), ...

HIMS accelerates global expansion with tech-integrated care, leveraging ZAVA and semaglutide for personalized health delivery.

Progressive activists in Hassan demand timely opening of super speciality hospital for improved health services.

Hims & Hers Health is upgraded to a speculative Buy after a 20% drop, with growth potential in GLP-1 sales outweighing key ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

When it comes to compounded Ozempic and other semaglutides, Dr. Goulden adds that they are not identical to their ...

Popular digital weight loss app, Noom (NOOM) undercuts Novo Nordisk's Wegovy by offering quarter-dose packs at $119 for the ...